IPSWICH, Mass., March 19, 2014 /PRNewswire/ -- New England Biolabs (NEB®) invites attendees of this year's Association of Biomedical Research Facilities (ABRF) annual meeting to a luncheon workshop, entitled, "Next Generation Sequencing with NEB: Sample Preparation and Partnering". Tailored to the unique challenges facing core facilities engaged in NGS library preparation, the workshop will feature presentations on how NEB currently supports and works with core labs, the latest updates to its NEBNext® NGS library preparation kits, and NGS workflow automation.
NEB scientists will also be presenting posters on issues relevant to the ABRF audience, entitled, "Enabling high-throughput discovery of the RNA transcription landscape using a directional RNA workflow and a combinatorial multiplexing approach" and "A fast, highly-multiplexed solution to NGS library prep with low nanogram DNA inputs."
"NEB is committed to improving the experience of core lab managers and clients by leveraging its expertise in enzymology and NGS library preparation," said Fiona Stewart, NEBNext Product Marketing Manager at NEB. "The NEBNext suite of products offers several advantages, including streamlined workflows, multiple and flexible product formats, and long product shelf lives."
ABRF 2014 is taking place March 22 – 25, in Albuquerque, New Mexico.
Tuesday, March, 25th
For additional information on the workshop, contact NEBNext@neb.com. For additional information on the NEBNext portfolio of NGS library prep kits, visit NEBNext.com.
NEW ENGLAND BIOLABS®, NEB®, NEBNEXT® are registered trademarks of New England Biolabs, Inc.
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.
SOURCE New England Biolabs